Allergy Treatment Market Report 2026

The allergy treatment market size has grown strongly in recent years. It will grow from $24.74 billion in 2025 to $26.56 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing prevalence of allergies worldwide, rising hospital and clinic allergy treatments, limited awareness of advanced immunotherapy, reliance on conventional antihistamines, expansion of retail pharmacy networks.

The allergy treatment market size is expected to see strong growth in the next few years. It will grow to $35.63 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to growing demand for personalized allergy care, technological advancements in immunotherapy delivery, expansion of online pharmacy channels, increasing investment in allergy research, rising prevalence of pediatric and adult asthma and rhinitis. Major trends in the forecast period include rising adoption of anti-allergy drugs and immunotherapy, increasing awareness of allergy management and prevention, expansion of homecare and specialty clinic services, growing focus on personalized allergy treatments, rising use of nasal and oral administration routes.

The increasing prevalence of allergic conditions is anticipated to drive the expansion of the allergy treatment market in the coming years. An allergic condition occurs when the immune system reacts excessively to an allergen, typically a harmless substance. Allergy treatments involve therapies using either over-the-counter or prescription medications that help identify and avoid various allergy triggers, thereby preventing allergic reactions, reducing symptoms, minimizing the severity of allergies, and enhancing overall well-being. For instance, in April 2024, according to Allergy UK, a national charity in the UK, over 21 million people in the UK are affected by allergies, which had become the most commonly reported chronic health condition in 2022. Projections suggest that by 2026, half of Europe’s population will experience at least one allergy. Therefore, the rising prevalence of allergic conditions is fueling the growth of the allergy treatment market.

Major players in the allergy treatment market are emphasizing the adoption of advanced technologies to improve patient care, enhance treatment delivery, and optimize diagnostic and therapeutic results. Technological advancements in allergy treatment include digital health platforms, telehealth services, wearable monitoring devices, and precision immunotherapy solutions, which facilitate streamlined patient management, track allergic reactions, and offer personalized treatment options. For instance, in May 2023, Metropolis Healthcare Limited, an India-based network of pathology labs and diagnostic centers, introduced AI-powered allergy component testing based on Component Resolved Diagnostics (CRD). This component testing leverages artificial intelligence to assist physicians in making well-informed clinical decisions and provides valuable insights for tailoring and optimizing individual allergic disease treatment plans. It utilizes a nanotechnology-based multiplex system that identifies specific IgE antibodies against 295 allergens through a simple blood test and delivers results for 158 food allergens, ten contact allergens, and 127 respiratory allergens.

In June 2024, Ewopharma AG, a Switzerland-based provider of pharmaceuticals, consumer health products, and commercial healthcare services, acquired AllergyCare AG for an undisclosed sum. Through this acquisition, Ewopharma aims to strengthen its footprint in the Swiss pharmaceutical market by expanding into allergy prevention and treatment, leveraging established local expertise, sales capabilities, and strategic brand partnerships. AllergyCare AG is a Switzerland-based provider of pharmaceutical and consumer health products specializing in the prevention and treatment of allergies through dedicated distribution and marketing services.

Major companies operating in the allergy treatment market are Pfizer Inc., Johnson and Johnson, Allergy Therapeutics PLC, F. Hoffmann-La Roche Ltd, AbbVie Inc., Novartis AG, Merck & Co. Inc., Sanofi S.A., Thermo Fisher Scientific Inc., AstraZeneca, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals, Bausch Health Companies Inc., Teva Pharmaceutical Industries Ltd., Almirall S.A, Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, ALK-Abelló A/S, Stallergenes Greer International AG, Adamis Pharmaceuticals, HollisterStier Allergy, Leti Pharma SL.

North America was the largest region in the allergy treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allergy treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the allergy treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the allergy treatment market by increasing costs for imported drugs, immunotherapy kits, and delivery devices. Segments such as antihistamines, corticosteroids, and allergy shots are most impacted, with regions like north america, europe, and asia-pacific facing higher import duties. These tariffs have resulted in higher treatment costs and supply chain delays. However, they have also encouraged local production, development of domestic formulations, and innovation in cost-effective allergy treatment solutions.

The allergy treatment market research report is one of a series of new reports that provides allergy treatment market statistics, including allergy treatment industry global market size, regional shares, competitors with a allergy treatment market share, detailed allergy treatment market segments, market trends and opportunities, and any further data you may need to thrive in the allergy treatment industry. This allergy treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Allergy treatment refers to the control and relief of allergic responses and symptoms caused by hypersensitivity to specific allergens. These treatments are provided to lessen or eliminate symptoms, enhance the quality of life, and prevent or minimize future allergic responses.

The main allergy treatment includes anti-allergy drugs and immunotherapy. An antiallergic drug refers to a medicine that prevents or relieves allergies, where these drugs are frequently used to treat symptoms caused by allergies and stop the symptoms of allergies by reducing or blocking histamines. The various allergies are eye allergy, skin allergy, food allergy, asthma, rhinitis, and others that use different routes of administration such as oral, parenteral, nasal, and others. These are distributed via hospital pharmacies, retail pharmacies, online retailers, and others by end-users such as hospitals, specialty clinics, home care, and others.

The allergy treatment market consists of revenues earned by entities by providing various therapies such as adjunct therapy, investigational therapies, immune modulation, immunotherapy (OIT), and sublingual immunotherapy (SLIT). The market value includes the value of related goods sold by the service provider or included within the service offering. The allergy treatment market also includes sales of nasal corticosteroids, antihistamines mast cell stabilizers, decongestants, corticosteroid creams or ointments, oral corticosteroids, and epinephrine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.